Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

被引:243
作者
Mikova, O
Yakimova, R
Bosmans, E
Kenis, G
Maes, M
机构
[1] Univ Hosp Maastricht, Dept Psychiat & Neuropsychol, NL-6202 AZ Maastricht, Netherlands
[2] Med Univ Sofia, Dept Psychiat, Sofia, Bulgaria
[3] Eurogenet, Tessenderlo, Belgium
[4] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
关键词
depression; cytokines; tumor necrosis factor; multiple sclerosis; interleukin;
D O I
10.1016/S0924-977X(01)00081-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is now evidence that major depression is accompanied by activation of the inflammatory response system (IRS) as indicated by an increased production of pro-inflammatory cytokines. There is circumstantial evidence implicating pro-inflammatory cytokines, such as tumor neurosis factor-alpha (TNF alpha) in the pathogenesis of multiple sclerosis (MS). The aims of the present study were to examine (i) the serum concentrations of interleukin-6 (IL-6), IL-8, TNF alpha, IL-2 receptor (IL-2R) and CC16 (uteruglobulin), an endogenous anti-cytokine, in depressed and MS patients compared to normal controls, and (ii) the effects of treatment with antidepressants on the above IRS variables in depressed patients. Serum TNF alpha was significantly higher in depressed and MS patients than in normal controls. Serum IL-8 was significantly higher in depressed patients than in patients with MS. Serum CC16 was significantly higher in patients with MS than in normal controls and depressed patients. Nonresponders to treatment with antidepressants had significantly higher serum IL-2R and lower serum CC16 concentrations than responders to treatment. The results show that (i) depression is accompanied by activation of the IRS and that this activation is more pronounced in depression than in MS, and (ii) IRS activation in depressed patients is related to a nonresponse to treatment with antidepressants. (C) 2001 Elsevier Science B.V./ECNP. All rights reserved.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 44 条
[1]   HUMAN URINARY PROTEIN-1 - EVIDENCE FOR IDENTITY WITH THE CLARA CELL PROTEIN AND OCCURRENCE IN RESPIRATORY-TRACT AND UROGENITAL SECRETIONS [J].
BERNARD, A ;
ROELS, H ;
LAUWERYS, R ;
WITTERS, R ;
GIELENS, C ;
SOUMILLION, A ;
VANDAMME, J ;
DELEY, M .
CLINICA CHIMICA ACTA, 1992, 207 (03) :239-249
[2]  
Bitsch A, 2000, GLIA, V29, P366, DOI 10.1002/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO
[3]  
2-Y
[4]   Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally [J].
Bluthe, RM ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
NEUROREPORT, 1996, 7 (09) :1485-1488
[5]  
BONACCORSO S, 2000, CURR OPIN PSYCHIATR, P13
[6]   Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity. [J].
Carrieri, PB ;
Provitera, V ;
De Rosa, T ;
Tartaglia, G ;
Gorga, F ;
Perrella, O .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1998, 20 (03) :373-382
[7]  
CAVAILLON JM, 1996, CYTOKINES
[8]   Clara cell protein: Concentrations in cerebrospinal fluid, serum and amniotic fluid [J].
De Jongh, R ;
Vranken, J ;
Kenis, G ;
Bosmans, E ;
Maes, M ;
Stans, G ;
De Ley, M ;
Heylen, R .
CYTOKINE, 1998, 10 (06) :441-444
[9]   POTENT INHIBITION OF BOTH HUMAN INTERFERON-GAMMA PRODUCTION AND BIOLOGIC ACTIVITY BY THE CLARA CELL PROTEIN CC16 [J].
DIERYNCK, I ;
BERNARD, A ;
ROELS, H ;
DELEY, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 12 (02) :205-210
[10]  
EVANS DL, 1992, ARCH GEN PSYCHIAT, V49, P388